ABSTRACT Hepatitis A virus (HAV) infection is an uncommon indication for liver transplantation, and donor‐derived or transfusion‐associated HAV infection is rare. Data describing HAV recurrence or early acquisition following liver transplantation, particularly with longitudinal quantitative viral kinetics, are limited.
David Mutimer +3 more
wiley +1 more source
Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients. [PDF]
Wei Q, Zhao J.
europepmc +1 more source
ABSTRACT The introduction of potent, well‐tolerated direct‐acting antivirals (DAAs) has transformed hepatitis C virus (HCV) therapy and spurred global elimination efforts. However, the extensive genetic diversity of HCV may affect antiviral efficacy, particularly in low and middle‐income regions where limited data currently exist.
Win Min Han +11 more
wiley +1 more source
ABSTRACT Background and Aims Chronic hepatitis B (CHB) remains a major global health burden. Current therapies rarely achieve a functional cure due to low rates of HBsAg clearance, the persistence of the viral replication template—covalently closed circular DNA (cccDNA)—and the need for lifelong treatment.
Yuming Guo +22 more
wiley +1 more source
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B. [PDF]
Jiang B +13 more
europepmc +1 more source
Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley +1 more source
Virological response and predictive factors for antiviral treatment in chronic HBV-related liver disease with low ALT and high HBV DNA. [PDF]
Ma L, Li Y, Weng L, Xing H.
europepmc +1 more source
Abstract Objective Data on the long‐term stability and reproducibility of nucleic acid amplification testing (NAT) results in frozen stored positive samples (≤−20°C) remain limited. This study evaluated the long‐term performance of frozen virus‐positive samples in quantitative PCR assays and aimed to provide evidence for their analytical reliability in
Benjamin Marx +6 more
wiley +1 more source
Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings. [PDF]
D'souza S +7 more
europepmc +1 more source
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC. [PDF]
Li CL +9 more
europepmc +1 more source

